A render of a block of pure nickel. Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Only one day after selling a nickel plant – complete with rooms for 200 workers and laboratories on-site – Poseidon Nickel’s (ASX:POS) CEO Craig Jones is “departing to pursue other opportunities.”

Mineral Resources didn’t just buy a “plant” off Poseidon on Monday. It bought Poseidon’s entire flagship project.

Brendan Shalders, current POS CFO, will step up to the CEO role from the start of next month.

Notably, the company says it will be “well-funded to execute its strategy when the proposed sale of Lake Johnston is finalised.”

What exactly Poseidon’s strategy could feasibly be after selling the Lake Johnston project remains to be seen. Right now POS has $2 million in cash “which sufficiently funds the business.”

Read: the business won’t be getting up to much.

Today Poseidon spoke of giving the market information “on executive management changes and further cost reduction initiatives.”

“With the divestment of Lake Johnston, Black Swan remaining on C&M, the shift back to exploration and the continued focus on cost reduction, Craig Jones who has a strong operational background has decided to seek other opportunities,” Poseidon Chair Peter Harold said.

Whether or not Lake Johnston was truly a ‘divestment’ is probably impossible to prove. But given the entire company is facing a world where Indonesia has pushed down global nickel prices and disrupted operations at BHP, IGO, and elsewhere, it feels a little bit more like MinRes picked up a decent asset for cheap off a distressed company.

Especially seeing as MinRes are going to turn it into a lithium plant, ahead of the next upwind in the price cycle for Australia’s favourite battery metal.

POS last traded at 0.8c. It was worth 13c in July of 2021.

pos by the numbers
More From The Market Online

KGL Resources jumps 25% on US$300M funding deal

KGL Resources has entered into a US$300 million PMPA to help fund construction and development of…
London

With osteo Phase 3 trial at 50% recruitment, Paradigm Bio inks partnership with University of London

Paradigm Biopharma (ASX:PAR) has this week hit two big items out the park: first of all, hitting 50% recruitment

Terra hits multiple intersections at Southwest SW6 prospect; assays now due in next ~12 weeks

Terra Metals has hit multiple intersections of massive sulphides in drilling at the Southwest SW6 prospect…

Listen: HotCopper Wire Podcast #047 – Maybe just send an email next time, Albo

In this week’s HotCopper Wire episode, Isaac McIntyre and Jonathon Davidson break down (poke holes in) Albo’s national address from 7PM Wednesday, talk